Faelli Nadia, Chironi Federica, Andrenacci Beatrice, Patria Maria Francesca, Ferrero Stefano, Borzani Irene, Pucci Costanza, Civeriati Daniela, Lelii Mara, Madini Barbara, Rocchi Alessia, Daccò Valeria
Department of Pediatrics, Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
Università degli Studi di Milano, Milano, Italy.
Ital J Pediatr. 2025 Jul 7;51(1):212. doi: 10.1186/s13052-025-02018-3.
Childhood interstitial lung disease (chILD) encompasses a heterogeneous group of rare disorders characterized by respiratory distress, hypoxemia, exercise intolerance, and distinctive radiological findings. Despite the variable age of onset, these conditions often present with overlapping symptoms and variable progression, even with identical genetic mutations. Surfactant protein deficiencies fall under the category of chILD, with Surfactant Protein-C (SP-C) deficiency posing significant diagnostic challenges due to its rarity and the variable severity of clinical presentation.
We present the case of a 15-year-old male from Senegal who recently arrived in Italy, presenting with severe respiratory distress and hypoxemia. The patient, born full-term, had a long history of chronic cough, recurrent respiratory distress, and poor growth since early infancy. Upon hospitalization, he tested positive for SARS-CoV-2 and exhibited signs of chronic respiratory failure and severe malnutrition. An extensive diagnostic work-up, including a chest CT scan, revealed small cystic-like air spaces and diffuse ground-glass opacities. Whole-exome sequencing confirmed the diagnosis of SP-C deficiency by identifying a heterozygous missense mutation (c.218t>C, Ile73Thr) in the third exon of the SFTPC gene. Treatment with steroids, azithromycin and hydroxychloroquine was initiated. Despite pharmacological treatments, the patient remained oxygen dependent due to the severity of this condition and required long-term bilevel non-invasive ventilatory support.
This case provides insight into the natural course of untreated child, specifically SP-C deficiency, enhancing our understanding of its manifestations and progression. The lack of standardized treatments underscores the critical need for increased awareness among physicians of this rare but potentially life-threatening condition, enabling early diagnosis and timely therapeutic interventions.
儿童间质性肺疾病(chILD)包括一组异质性罕见疾病,其特征为呼吸窘迫、低氧血症、运动不耐受以及独特的影像学表现。尽管发病年龄各异,但这些疾病常表现出重叠症状且进展不一,即便存在相同的基因突变也是如此。表面活性物质蛋白缺乏症属于chILD范畴,其中表面活性物质蛋白C(SP - C)缺乏症因其罕见性和临床表现的严重程度不一而带来了重大的诊断挑战。
我们报告一例来自塞内加尔的15岁男性病例,该患者近期抵达意大利,出现严重呼吸窘迫和低氧血症。患者足月出生,自婴儿早期起就有慢性咳嗽、反复呼吸窘迫及生长发育不良的病史。住院时,他新冠病毒检测呈阳性,并表现出慢性呼吸衰竭和严重营养不良的体征。包括胸部CT扫描在内的广泛诊断检查显示有小囊状气腔和弥漫性磨玻璃影。全外显子组测序通过在SFTPC基因第三外显子中鉴定出一个杂合错义突变(c.218t>C,Ile73Thr)确诊为SP - C缺乏症。开始使用类固醇、阿奇霉素和羟氯喹进行治疗。尽管进行了药物治疗,但由于病情严重,患者仍依赖氧气,并需要长期双水平无创通气支持。
该病例为未治疗儿童,特别是SP - C缺乏症的自然病程提供了见解,增进了我们对其表现和进展的理解。缺乏标准化治疗凸显了医生提高对这种罕见但可能危及生命疾病认识的迫切需求,以便能够早期诊断并及时进行治疗干预。